Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Baril JG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-16 z 16
    Tytuł:
    Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
    Autorzy:
    Doyle CM; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
    Milwid RM; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
    Cox J; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.; Direction Régionale de Santé Publique de Montréal, Montréal, Québec, Canada.; Clinical Outcomes Research and Evaluation, Research Institute - McGill University Health Centre, Montréal, Québec, Canada.
    Xia Y; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
    Lambert G; Direction Régionale de Santé Publique de Montréal, Montréal, Québec, Canada.
    Tremblay C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.
    Otis J; Département de Sexologie, Université du Québec à Montréal, Montréal, Québec, Canada.
    Boily MC; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
    Baril JG; Department of Family Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Clinique de médecine urbaine du Quartier Latin, Montréal, Québec, Canada.
    Thomas R; Clinique médicale l'Actuel, Montréal, Québec, Canada.
    Blais AD; RÉZO Health and STI prevention for GBQ men, trans people and MSM, Montréal, Québec, Canada.
    Trottier B; Clinique de médecine urbaine du Quartier Latin, Montréal, Québec, Canada.
    Grace D; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
    Moore DM; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
    Mishra S; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
    Maheu-Giroux M; Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Québec, Canada.
    Pokaż więcej
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2023 Dec; Vol. 26 (12), pp. e26194.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    HIV Infections*/epidemiology
    HIV Infections*/prevention & control
    Pre-Exposure Prophylaxis*/methods
    Sexual and Gender Minorities*
    Anti-HIV Agents*/therapeutic use
    Male ; Humans ; Aged ; Homosexuality, Male ; Pandemics ; Sexual Behavior ; Canada/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The Frequency and Function of NKG2C Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy.
    Autorzy:
    Alsulami K; Research Institute of the McGill University Health Centre (RI-MUHC), Glen Site, Bloc E, 1001 Decarie Blvd., Room EM3.3238, Montreal, QC H4A 3J1, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Infectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
    Dupuy FP; Research Institute of the McGill University Health Centre (RI-MUHC), Glen Site, Bloc E, 1001 Decarie Blvd., Room EM3.3238, Montreal, QC H4A 3J1, Canada.; Infectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
    Gilbert L; Research Institute of the McGill University Health Centre (RI-MUHC), Glen Site, Bloc E, 1001 Decarie Blvd., Room EM3.3238, Montreal, QC H4A 3J1, Canada.; Infectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
    Messier-Peet M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.
    Durand M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.
    Tremblay C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.; Department of Microbiology Infectiology and Immunology, University of Montreal, Montreal, QC H3C 3J7, Canada.
    Routy JP; Research Institute of the McGill University Health Centre (RI-MUHC), Glen Site, Bloc E, 1001 Decarie Blvd., Room EM3.3238, Montreal, QC H4A 3J1, Canada.; Infectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.; Division of Hematology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
    Bruneau J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.; Department of Family Medicine and Emergency Medicine, Université de Montréal, Montreal, QC H3X 0A9, Canada.
    Baril JG; Clinique de Médecine Urbaine du Quartier Latin, Montreal, QC H2L 4E9, Canada.
    Trottier B; Clinique de Médecine Urbaine du Quartier Latin, Montreal, QC H2L 4E9, Canada.
    Bernard NF; Research Institute of the McGill University Health Centre (RI-MUHC), Glen Site, Bloc E, 1001 Decarie Blvd., Room EM3.3238, Montreal, QC H4A 3J1, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Infectious Diseases, Immunology and Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.; Division of Clinical Immunology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2023 Jan 24; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 24.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Coinfection*
    Cytomegalovirus Infections*/complications
    HIV Infections*/complications
    HIV Infections*/drug therapy
    Aged ; Aged, 80 and over ; Humans ; Killer Cells, Natural ; Tumor Necrosis Factor-alpha ; CD57 Antigens/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).
    Autorzy:
    Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, Canada.
    Young J; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
    Ortiz-Paredes D; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
    Wang S; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
    Walmsley S; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, Canada.; University Health Network, University of Toronto, Toronto, Canada.
    Wong A; Department of Medicine, University of Saskatchewan, Regina, Canada.
    Martel-Laferrière V; Department of Microbiology and Infectious Diseases, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Canada.
    Pick N; Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
    Conway B; Vancouver Infectious Diseases Centre, Vancouver, Canada.
    Angel J; Ottawa Hospital Research Institute, Ottawa, Canada.
    Baril JG; Clinique de Médecine Urbaine du Quartier Latin, Montreal, Canada.
    Fraser C; Cool Aid Community Health Centre, Victoria, Canada.
    Lebouché B; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.; Department of Family Medicine, McGill University, Montreal, Canada.
    Tan DHS; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
    Sandre R; HAVEN Program, Health Sciences North, Sudbury, Canada.
    Trottier S; Centre de Recherche du CHU de Québec, Department of Microbiology, Infectiology and Immunology, Université Laval, Quebec, Canada.
    Peiris H; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
    Jayaraman J; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, Canada.
    Singer J; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, Canada.
    Pokaż więcej
    Corporate Authors:
    CTN 286 Study Investigators
    Źródło:
    Patient preference and adherence [Patient Prefer Adherence] 2022 Dec 13; Vol. 16, pp. 3267-3281. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study.
    Autorzy:
    Sutton KC; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
    De Vente J; Long Beach Education and Research Consultants, Long Beach, California, USA.
    Leblanc R; Clinique OPUS Inc., Montreal, Quebec, Canada.
    Dejesus E; Orlando Immunology Center, Orlando, Florida, USA.
    Smith G; Maple Leaf Research, Toronto, Ontario, Canada.
    Mills A; Men's Health Foundation, Los Angeles, California, USA.
    Baril JG; Clinique Medicale Quartier Latin, Montreal, Quebec, Canada.
    St Clair M; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
    Stancil BS; GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
    Vandermeulen K; Janssen Research and Development, Beerse, Belgium.
    Spreen WR; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Feb 09; Vol. 9 (4), pp. ofac067. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020).
    Autorzy:
    Brenner BG; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC H4A 3J1, Canada.; Department of Medicine (Surgery, Infectious Disease), McGill University, Montréal, QC H3A 2M7, Canada.
    Ibanescu RI; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.
    Osman N; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC H4A 3J1, Canada.
    Cuadra-Foy E; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC H4A 3J1, Canada.
    Oliveira M; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.
    Chaillon A; Department of Medicine, University of California, San Diego, CA 93903, USA.
    Stephens D; Department of Mathematics and Statistics, McGill University, Montréal, QC H3A 0B9, Canada.
    Hardy I; Département de Microbiologie et d'Immunologie et Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC H2X 0C1, Canada.
    Routy JP; Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H3A 3J1, Canada.
    Thomas R; Clinique Médicale l'Actuel, Montréal, QC H2L 4P9, Canada.
    Baril JG; Clinique Médicale Urbaine du Quartier Latin, Montréal, QC H2L 4E9, Canada.
    Leblanc R; Clinique Médicale OPUS, Montréal, QC H3A 1T1, Canada.
    Tremblay C; Département de Microbiologie et d'Immunologie et Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC H2X 0C1, Canada.
    Roger M; Département de Microbiologie et d'Immunologie et Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC H2X 0C1, Canada.
    The Montreal Primary Hiv Infection Phi Cohort Study Group; Montreal PHI Cohort of the Réseau Sida et Maladies Infectieuses, Centre de Recherche du CHUM, Montréal, QC H2X 0A9, Canada.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2021 Aug 19; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 19.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Phylogeny*
    HIV Infections/*transmission
    HIV Infections/*virology
    HIV-1/*genetics
    Adult ; Aged ; Aged, 80 and over ; Epidemics ; Female ; HIV Infections/epidemiology ; HIV-1/classification ; HIV-1/isolation & purification ; HIV-1/physiology ; Homosexuality, Male/statistics & numerical data ; Humans ; Male ; Middle Aged ; Quebec/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
    Autorzy:
    Sangaré MN; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.; Sainte Justine University Hospital Center, Montreal, Québec, Canada.
    Baril JG; Clinique de Médecine Urbaine du Quartier Latin, Montreal, Québec, Canada.; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.
    de Pokomandy A; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Québec, Canada.; Department of Family Medicine, Faculty of Medicine, McGill University, Montreal, Québec, Canada.
    Ferreira Guerra S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
    Carabali M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
    Laprise C; Division of Oral Health and Society, McGill University, Montreal, Québec, Canada.
    Thomas R; Clinique Médicale L'Actuel, Montreal, Québec, Canada.
    Klein M; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Québec, Canada.
    Tremblay C; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Québec, Canada.
    Roger M; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Québec, Canada.
    Pexos C; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Québec, Canada.
    Greenwald ZR; Clinique Médicale L'Actuel, Montreal, Québec, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
    Machouf N; Clinique de Médecine Urbaine du Quartier Latin, Montreal, Québec, Canada.
    Durand M; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Québec, Canada.
    Hardy I; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Microbiology and Infectiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
    Dakouo M; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.
    Trevisan A; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.; Sainte Justine University Hospital Center, Montreal, Québec, Canada.
    Laporte L; Sainte Justine University Hospital Center, Montreal, Québec, Canada.
    Schnitzer ME; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.; Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada.
    Trottier H; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.; Sainte Justine University Hospital Center, Montreal, Québec, Canada.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2020 Sep 04; Vol. 7 (11), pp. ofaa404. Date of Electronic Publication: 2020 Sep 04 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate.
    Autorzy:
    Huhn GD; The Ruth M Rothstein CORE Center, Chicago, Illinois, USA.
    Shamblaw DJ; La Playa Medical Group and Clinical Research, San Diego, California, USA.
    Baril JG; Clinique Medicale Du Quartier Latin, Montreal, Canada.
    Hsue PY; San Francisco General Hospital, San Francisco, California, USA.
    Mills BL; Gilead Sciences, Foster City, California, USA.
    Nguyen-Cleary T; Gilead Sciences, Foster City, California, USA.
    McCallister S; Gilead Sciences, Foster City, California, USA.
    Das M; Gilead Sciences, Foster City, California, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2019 Nov 11; Vol. 7 (1), pp. ofz472. Date of Electronic Publication: 2019 Nov 11 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.
    Autorzy:
    Mehraj V; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
    Cox J; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
    Lebouché B; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Department of Family Medicine, McGill University, Montreal, QC, Canada.
    Costiniuk C; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
    Cao W; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Department of Infectious Diseases, Peking Union Medical College Hospital, Beijing, China.
    Li T; Department of Infectious Diseases, Peking Union Medical College Hospital, Beijing, China.
    Ponte R; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
    Thomas R; Clinique Médicale l'Actuel, Montréal, QC, Canada.
    Szabo J; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Clinique Médicale l'Actuel, Montréal, QC, Canada.
    Baril JG; Clinique Médicale Quartier Latin, Montréal, QC, Canada.
    Trottier B; Clinique Médicale Quartier Latin, Montréal, QC, Canada.
    Côté P; Clinique Médicale Quartier Latin, Montréal, QC, Canada.
    LeBlanc R; Clinique Médicale OPUS, Montréal, QC, Canada.
    Bruneau J; Centre de recherche du Centre Hospitalier de l', Université de Montréal, Montréal, QC, Canada.
    Tremblay C; Centre de recherche du Centre Hospitalier de l', Université de Montréal, Montréal, QC, Canada.; Département de microbiologie infectiologie et immunologie, Université de Montréal, Montréal, QC, Canada.
    Routy JP; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Division of Hematology, McGill University Health Centre, Montreal, QC, Canada.
    Pokaż więcej
    Corporate Authors:
    Montreal Primary HIV-Infection Study Group
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2018 Feb; Vol. 21 (2).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/immunology ; Humans ; Male ; Prospective Studies ; Social Class ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Autorzy:
    Durand M; Internal Medicine service, Centre de Recherche du CHUM, Montréal, QC, H2J 1T8, Canada. .
    Chartrand-Lefebvre C; Department of Radiology, Centre hospitalier de l'Université de Montréal, Montréal, Canada.
    Baril JG; Clinique médicale urbaine du Quartier latin, Montreal, Canada.
    Trottier S; Clinique médicale urbaine du Quartier latin, Montreal, Canada.
    Trottier B; Clinique médicale urbaine du Quartier latin, Montreal, Canada.
    Harris M; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.
    Walmsley S; Division of Infectious Diseases, University Health Network, Toronto, Canada.
    Conway B; Division of Infectious Diseases, University Health Network, Toronto, Canada.
    Wong A; Infectious Diseases Clinic, Regina Qu'Appelle Health Region, Regina, Canada.
    Routy JP; Chronic viral infection service and Division of Hematology, McGill University Health Centre, Montreal, Canada.
    Kovacs C; Maple Leaf Medical HIV Research Collaborative Inc., Toronto, Canada.
    MacPherson PA; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Canada.
    Monteith KM; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Canada.
    Mansour S; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Canada.
    Thanassoulis G; Preventive and Genomic Cardiology, McGill University Health Center and Research Institute, Montreal, Canada.
    Abrahamowicz M; Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
    Zhu Z; Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
    Tsoukas C; McGill University, Immunology service, Montreal General Hospital, Montreal, Canada.
    Ancuta P; Centre de recherche du CHUM, Montreal, Canada.
    Bernard N; Research Institute of the McGill University Health Center, Division of Experimental Medicine, McGill University, Division of Clinical Immunology, McGill University health Center (MUHC), Chronic Viral Illness Service, Montreal, Canada.
    Tremblay CL; Centre de recherche du CHUM, Montreal, Canada.
    Pokaż więcej
    Corporate Authors:
    investigators of the Canadian HIV and Aging Cohort Study
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2017 Sep 11; Vol. 17 (1), pp. 611. Date of Electronic Publication: 2017 Sep 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Aging/*physiology
    Cardiovascular Diseases/*epidemiology
    Cardiovascular Diseases/*etiology
    HIV Infections/*complications
    Adult ; Aged ; Biomarkers ; Canada/epidemiology ; Chronic Disease ; Cohort Studies ; Comorbidity ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Female ; HIV Infections/epidemiology ; Humans ; Incidence ; Inflammation/etiology ; Inflammation/virology ; Male ; Middle Aged ; Multicenter Studies as Topic ; Myocardial Infarction/epidemiology ; Myocardial Infarction/etiology ; Prospective Studies ; Risk Factors ; Stroke/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.
    Autorzy:
    El-Far M; CHUM-Research Centre, Montréal, QC, Canada.
    Kouassi P; CHUM-Research Centre, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de, Montréal, QC, Canada.
    Sylla M; CHUM-Research Centre, Montréal, QC, Canada.
    Zhang Y; CHUM-Research Centre, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de, Montréal, QC, Canada.
    Fouda A; CHUM-Research Centre, Montréal, QC, Canada.
    Fabre T; CHUM-Research Centre, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de, Montréal, QC, Canada.
    Goulet JP; Caprion, Montréal, QC, Canada.
    van Grevenynghe J; INRS-Institut Armand Frappier, Laval, QC, Canada.
    Lee T; CIHR Canadian HIV Trials Network, St. Paul's Hospital, Vancouver, BC, Canada.
    Singer J; CIHR Canadian HIV Trials Network, St. Paul's Hospital, Vancouver, BC, Canada.
    Harris M; AIDS Research Program, St. Paul's Hospital, Vancouver, BC, Canada.
    Baril JG; Clinique Médicale Quartier Latin, Montréal, QC, Canada.
    Trottier B; Clinique Médicale l'Actuel, Montréal, QC, Canada.
    Ancuta P; CHUM-Research Centre, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de, Montréal, QC, Canada.
    Routy JP; Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC, Canada.
    Bernard N; Research Institute, McGill University Health Centre, Montréal, QC, Canada.
    Tremblay CL; CHUM-Research Centre, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de, Montréal, QC, Canada.
    Pokaż więcej
    Corporate Authors:
    Investigators of the Canadian HIV+ Slow Progressor Cohort
    Źródło:
    Scientific reports [Sci Rep] 2016 Mar 15; Vol. 6, pp. 22902. Date of Electronic Publication: 2016 Mar 15.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers/*blood
    HIV Infections/*blood
    Inflammation Mediators/*blood
    Interleukins/*blood
    Adult ; CD4 Lymphocyte Count ; CD4-CD8 Ratio ; Cells, Cultured ; Cohort Studies ; Disease Progression ; Enzyme-Linked Immunosorbent Assay ; Female ; Gene Expression Profiling/methods ; HIV Infections/genetics ; HIV Infections/immunology ; HIV-1/immunology ; Humans ; Interleukin-6/blood ; Interleukin-6/genetics ; Interleukins/genetics ; Lipopolysaccharide Receptors/blood ; Lipopolysaccharide Receptors/genetics ; Male ; Oligonucleotide Array Sequence Analysis ; Protein Isoforms/blood ; Protein Isoforms/genetics ; Viral Load/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.
    Autorzy:
    Baril JG; Clinique médicale du Quartier latin, Montreal, Quebec, Canada.
    Angel JB; Division of Infectious Diseases, University of Ottawa and the Ottawa Hospital, Ottawa, Ontario, Canada.
    Gill MJ; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
    Gathe J; Therapeutic Concepts, Houston, Texas, United States of America.
    Cahn P; Fundación Huesped, Buenos Aires, Argentina.
    van Wyk J; AbbVie Inc., North Chicago, Illinois, United States of America.
    Walmsley S; Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Feb 05; Vol. 11 (2), pp. e0148231. Date of Electronic Publication: 2016 Feb 05 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV/*drug effects
    HIV Infections/*drug therapy
    HIV Infections/*virology
    Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/pharmacology ; Clinical Trials as Topic ; Drug Combinations ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load.
    Autorzy:
    Charest H; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada.
    Doualla-Bell F; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Department of Medicine, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
    Cantin R; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
    Murphy DG; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
    Lemieux L; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
    Brenner B; McGill AIDS Center, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
    Hardy I; Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
    Moisi D; McGill AIDS Center, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
    Lo E; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
    Baril JG; Clinique du Quartier Latin, Montréal, Québec, Canada.
    Wainberg MA; McGill AIDS Center, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
    Roger M; Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada; Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
    Tremblay C; Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada; Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Oct 08; Vol. 9 (10), pp. e109420. Date of Electronic Publication: 2014 Oct 08 (Print Publication: 2014).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Drug Resistance, Viral*/genetics
    HIV-1/*drug effects
    HIV-1/*physiology
    Viral Load/*drug effects
    Anti-HIV Agents/pharmacology ; Epidemiological Monitoring ; HIV-1/genetics ; Humans ; Mutation ; Quebec/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.
    Autorzy:
    Papuchon J; University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.
    Pinson P; University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.
    Guidicelli GL; University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France.
    Bellecave P; University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.
    Thomas R; Clinique médicale l'Actuel, Montréal, Canada.
    LeBlanc R; Clinique médicale Opus, Montréal, Canada.
    Reigadas S; University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.
    Taupin JL; University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France.
    Baril JG; Clinique Médicale du Quartier Latin, Montréal, Canada.
    Routy JP; McGill University Health Centre, Montréal, Canada.
    Wainberg M; McGill AIDS Centre, Montréal, Canada.
    Fleury H; University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.
    Pokaż więcej
    Corporate Authors:
    Provir/Latitude 45 study group
    Źródło:
    PloS one [PLoS One] 2014 Jun 25; Vol. 9 (6), pp. e100452. Date of Electronic Publication: 2014 Jun 25 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Alleles*
    Epitopes, T-Lymphocyte/*immunology
    HIV Infections/*genetics
    HIV-1/*immunology
    HLA-A Antigens/*genetics
    HLA-A Antigens/*immunology
    T-Lymphocytes, Cytotoxic/*immunology
    Cohort Studies ; HIV Infections/immunology ; HIV-1/physiology ; Humans ; Kinetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.
    Autorzy:
    Routy JP; Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada. />Tremblay CL
    Angel JB
    Trottier B
    Rouleau D
    Baril JG
    Harris M
    Trottier S
    Singer J
    Chomont N
    Sékaly RP
    Boulassel MR
    Pokaż więcej
    Źródło:
    HIV medicine [HIV Med] 2012 May; Vol. 13 (5), pp. 291-6. Date of Electronic Publication: 2012 Jan 26.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antiretroviral Therapy, Highly Active*
    CD4-Positive T-Lymphocytes/*virology
    Enzyme Inhibitors/*therapeutic use
    HIV Infections/*drug therapy
    HIV-1/*drug effects
    Valproic Acid/*therapeutic use
    Virus Latency/*drug effects
    Adult ; Aged ; Aged, 80 and over ; Cross-Over Studies ; Drug Therapy, Combination/methods ; Female ; HIV Infections/virology ; HIV-1/physiology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-16 z 16

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies